Institutional Career Development Core

机构职业发展核心

• 批准号: 10153915
• 负责人: Sheri L Robb
• 金额: $ 103.75万
• 依托单位: INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-05-18 至 2023-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10153915
• 关键词: Active Learning; Area; Award; Clinical Sciences; Collaborations; Communities; Complement; Discipline; Entrepreneurship; Ethnic Origin; Foundations; Funding; Gender; Indiana; Industry; Innovation Corps; Institutes; Mentors; Modeling; Positioning Attribute; Principal Investigator; Program Evaluation; Race; Regulatory Affairs; Research; Research Ethics; Research Personnel; Research Training; Science; Testing; Time; Training; Training Programs; Training and Education; Translational Research; Underrepresented Minority; Universities; Woman; career; career development; clinical development; design; drug development; faculty mentor; flexibility; industry partner; innovation; mentoring community; mid-career faculty; minority scientist; novel; peer; population health; program dissemination; programs; recruit; translational scientist

I. INSTITUTIONAL CAREER DEVELOPMENT CORE (KL2) SUMMARY/ABSTRACT The Indiana Clinical and Translational Sciences Institute (CTSI) has a sustained record of accomplishment of training KL2 Scholars through its Career development, Education and Research Training (CERT) Program. Notably, CERT has trained 47 KL2 Scholars, with most retained in academic positions (92%), spending a median of 75% of their time in research, being promoted to Associate Professor (43%), and obtaining external funding as principal investigators (95%) including 14 R01s, 7 other R-level awards and 15 K or equivalent career awards. These 47 Scholars have come from 29 different disciplines, have been diverse in terms of gender (46% women) and race/ethnicity (15% underrepresented minorities), and are nicely distributed across the spectrum of T1 through T4 research. An additional strength is the fact that our Scholars are recruited from the 3 major research universities in the state: Indiana University, Purdue University, and the University of Notre Dame. This expands the pool or Scholars, faculty mentors, and breadth of translational research. In this application, we propose a number of new and innovative training initiatives that build upon our foundational programs. We designed the four specific aims of the KL2 Career Development Core Program to maximize its impact on the training and career development of clinical and translational scientists at an institutional, regional, and national level. 1) Increase the flexibility and reach of our foundational programs for personalize research training and accelerate mentored-to-independent investigator (K to R) status. 2) Add training in areas where our CERT program has unique strengths as well as gaps. Key domains include implementation, community-engagement, regulatory affairs, and population health. 3) Develop research training in 3 new areas: team science, entrepreneurship, and experiential learning. 4) Test innovative training approaches through research and national collaborations. We employ the continuous innovation cycle of “4Ds” in all of our CTSI activities: Design, Demonstrate, Duplicate, and Disseminate. We also plan innovative initiatives that can serve as model programs for dissemination more broadly. These include a) peer and community mentoring programs to complement our already robust faculty-mentoring program: b) an inter-CTSA KL2 Scholar exchange program; c) an I-Corps training course that serve regional CTSA programs; d) national coordination of an on-line CTSA-industry training program in drug development conducted in collaboration with Lilly, our founding industry partner. We are optimizing program evaluation utilizing NCATS common metrics augmented with novel metrics. We are enhancing recruitment and retention of underrepresent minority scientists, and offering a new course in translational research ethics.

I. Internitation Ixparion Development Core（KL2） 摘要/摘要 印第安纳州临床和转化科学研究所（CTSI）持续记录 通过其职业发展，教育和研究培训（CERT）计划培训KL2学者。 值得注意的是，CERT培训了47个KL2学者，其中大多数保留在学术职位（92％），花费了 他们在研究时间的75％的中位数被提升为副教授（43％） 作为首席调查员的资金（95％），包括14个R01，其他7个R级奖项和15K或同等学历 职业奖。这47名学者来自29个不同的学科 性别（46％的妇女）和种族/种族（少数族裔占15％），分布在 T1通过T4研究的范围是额外的优势 该州的3所主要研究大学：印第安纳大学，普渡大学和大学 巴黎圣母院 应用程序，我们提出了许多建立Uur基础的新的创新培训计划 计划。 对机构临床和转化科学家的培训和职业发展的影响， 区域和国家一级。 研究培训并加速了指导到独立的研究者（K到R）。 我们的证书计划具有独特的优势和差距。 社区参与，监管事务和人口健康。 团队科学，企业家精神和体验式学习。 研究和国家合作。 活动：设计，演示，复制和传播。 作为更广泛的模型计划。 补充我们已经强大的教师课程的计划：b）CTSA Inter-CTSA KL2学者 交换计划； 协调在线CTSA-IIndustry培训培训计划在合作中进行的药物开发计划 与我们的创始行业合作伙伴礼来公司，我们正在利用NCATS的计划评估 我们正在增强招聘和保留不足的指标。 少数派科学家，并提供了翻译研究伦理的新课程。